Kenneth Frazier - Merck Insider

Chairman, CEO and Pres

Mr. Kenneth C. Frazier is Chairman of the Board, President, Chief Executive Officer of Merck Co., Inc. Mr. Frazier previously served as Executive Vice President and President, Global Human Health of the Company and Merck Sharp Dohme Corporationration
Age: 60  Chairman Since 2011      
908 735-1500  www.merck.com
Kenneth Frazier EducationFrazier also served as Executive Vice President and General Counsel of Merck Sharp & Dohme Corporationration . Director, Exxon Mobil Corporationrationration since 2009 and Pharmaceutical Research and Manufacturers of America since 2011. Trustee, The Pennsylvania State University and Cornerstone Christian Academy in Philadelphia, PA; Member, Board of Overseers of Weill Cornell Medical College and Graduate School of Medical Sciences, American Academy of Arts and Sciences, Council on Foreign Relations, the Council of the American Law Institute and the American Bar Association.

Management Efficiency

The company has Return on Asset of 0.06 % which means that on every $100 spent on asset it made $0.06 of profit. This is way below average. In the same way, it shows return on shareholders equity (ROE) of 0.12 % implying that it generated $0.12 on every 100 dollars invested.
The company has 26.41 B in debt with debt to equity (D/E) ratio of 0.57 which is OK given its current industry classification. Merck Co Inc has Current Ratio of 1.85 which is typical for the industry and considered as normal.

Similar Executives

Found 14 records

CHAIRMAN Since

Richard SchutterIncyte Corporation
2004
Mr CBEQuintiles Transnational Holding
N/A
John ClimaxICON Public Limited Company
2010
Dennis GillingsQuintiles Transnational Holding
2015
Julian BakerIncyte Corporation
2015
P VagelosRegeneron Pharmaceuticals Inc
1995
William RastetterIllumina Inc
2005
Jon SaxeSciClone Pharmaceuticals Inc
2009
Jay FlatleyIllumina Inc
2016
Roy VagelosRegeneron Pharmaceuticals Inc
1995
Ciaran MurrayICON Public Limited Company
2011
Herve HoppenotIncyte Corporation
2015
Thomas LynchICON Public Limited Company
2016
CBE GillingsQuintiles Transnational Holding
N/A

Entity Summary

Merck & Co., Inc. offer healthcare solutions worldwide. Merck Co Inc (MRK) is traded on New York Stock Exchange in USA. It is located in NEW JERSEY, U.S.A and employs 66,645 people. Merck is listed under Pharmaceutical Products category by Fama And French industry classification and specializes in Healthcare with concentration in Pharmaceuticals And Biosciences.
Fix your portfolio
By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations when you add Merck Co Inc to your portfolio
Top Management
Merck Co Inc Leadership Team
Thomas Glocer, Director
C Kidder, Director
Craig Thompson, Director
Rochelle Lazarus, Director
Michael Rosenblatt, President, Ph.D
Wendell Weeks, Director
Michael Holston, President
Paul Rothman, Director
Adele Ambrose, President
Joseph Romanelli, Executive
Mirian GraddickWeir, President, Ph.D
Peter Wendell, Director
Leslie Brun, Director
Julie Gerberding, President
Pamela Craig, Director, MBA
Patricia Russo, Director
Willie Deese, President
Rita Karachun, SVP
Robert Davis, CFO
Robert Kidder, Director
Thomas Cech, Director, Ph.D
Clark Golestani, EVP
William Harrison, Director
Bruce Kuhlik, EVP
Roger Perlmutter, President, Ph.D
Sanat Chattopadhyay, President
Adam Schechter, President
Carlos Represas, Director
Cuong Do, President
Richard DeLuca, President
Kenneth Frazier, Chairman
Robert JD, CFO
Bridgette Heller, President
Stock Performance
Merck Performance Indicators